HIF1A and neoplasm: At the same time, the platform released sunitinib and active oxygen to induce apoptosis and inhibit tumor angiogenesis, with increased expression of cleaved PARP and decreased levels of VEGFA, HIF-1α, survivin, and p-STAT3 (Jiang et al., 2021).